Dea hearing

Cannabis stocks are having a moment few in the industry expected this early in 2026. The AdvisorShares Pure US Cannabis ETF (MSOS) has climbed to its highest levels of the year, with a one-year net

The second day of the Drug Enforcement Administration's administrative hearing on cannabis rescheduling turned confrontational in the most substantive way possible: opponents of marijuana reform